SCRS Sites Directory

Search SCRS member sites. Discover current trials.

Part of IMA Clinical Research's nationwide site network and provides access to a broad and diverse patient population and specializes in investigative treatments for COVID-19, Alzheimer’s disease, fatty liver, high cholesterol, migraines, diabetes, hypertension and pain. The site’s patient-centric approach to care ensures both compliance and quality, fostering a positive environment to leverage over seventy years of experience and investigate the efficacy of new therapies and medicines.

IMA Clinical Research partners in the development of new medical treatments through a flexible, full-service clinical trial site network that provides extensive patient access and diversity. IMA Clinical Research provides a comprehensive network of clinical research sites and an array of over one hundred and eighty satellite locations, providing extensive, nationwide patient access. Furthermore, we have a rapidly growing database of over 400,000 patients and the ability to reach millions.

We a modern, tech-enabled operating model to deliver various study designs, including classic site-based, hybrid and fully decentralized trials. We established the Patient Outreach Center to connect with patients who aren’t typically seen onsite, promoting longitudinal engagement, improving data collection and bolstering patient retention. Coupled with centralized contracting and rigorous regulatory adherence, IMA Clinical Research is uniquely positioned to deliver quick startup and high-quality studies across the network.


Demographic Data

  • Start year clinical research2014
  • Phases of clinical studiesPhase II, Phase III, Phase IV
  • Types of studiesBiologics, Drugs, Medical Devices, Nutraceuticals, Vaccines
  • PopulationsAdolescent 11-17 yrs, Adult 18-64 yrs, Senior 65 yrs and over
  • Type of siteFreestanding
  • # of employees involved in research6
  • # of investigators4
  • Number of studies last year6
  • Days openMonday, Tuesday, Wednesday, Thursday, Friday, Saturday
  • Extended office hoursYes
  • Dry iceYes
  • Blinded pharmacistYes
  • Dedicated monitoring spaceYes
  • Internet access for the monitorYes
  • Onsite laboratoryYes
  • Central laboratoryYes
  • Infusion capabilityYes
  • Shipping optionsFedEx, UPS, DHL, Other
  • Contact for regulatory documentsCristina Morales
  • Regulatory phone number210-556-7976
  • # of days to turn around regulatory documents2 to 4 weeks
  • Type of IRB used by this siteCentral
  • How often does your local IRB meet?Weekly
  • Appropriate storage facilities for productYes
  • Able to appropriately store Schedule II drugsYes
  • # days to turn around budget and contract4 to 6 weeks